The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States

Naomi C. Sacks, Bridget E. Healey, Sajjad Raza, Philip L. Cyr, Gerhard Boerner, Ajay Sheshadri

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States'. Together they form a unique fingerprint.

Medicine & Life Sciences